1. Home
  2. STG vs ASMB Comparison

STG vs ASMB Comparison

Compare STG & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunlands Technology Group

STG

Sunlands Technology Group

N/A

Current Price

$6.40

Market Cap

112.4M

Sector

Real Estate

ML Signal

N/A

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$33.29

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STG
ASMB
Founded
2003
2005
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.4M
553.6M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
STG
ASMB
Price
$6.40
$33.29
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$43.40
AVG Volume (30 Days)
5.4K
140.2K
Earning Date
11-20-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.01
N/A
Revenue
$285,589,112.00
$37,191,000.00
Revenue This Year
N/A
$33.33
Revenue Next Year
N/A
N/A
P/E Ratio
$1.60
N/A
Revenue Growth
N/A
31.30
52 Week Low
$4.28
$7.75
52 Week High
$15.00
$39.71

Technical Indicators

Market Signals
Indicator
STG
ASMB
Relative Strength Index (RSI) 56.84 46.76
Support Level $5.49 $31.51
Resistance Level $6.48 $38.99
Average True Range (ATR) 0.33 2.15
MACD 0.12 -0.32
Stochastic Oscillator 86.67 25.13

Price Performance

Historical Comparison
STG
ASMB

About STG Sunlands Technology Group

Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: